The primary hyperoxaluriasBernd Höppe, Dawn S. Milliner, Bodo B. Beck|Kidney International|2009Cited by 373
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancyOliver Groß, Manfred Weber, Britta Höcker et al.|Kidney International|2011Cited by 361
ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signalingHeon Yung Gee, Friedhelm Hildebrandt, Pawaree Saisawat et al.|Journal of Clinical Investigation|2013Cited by 237
Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1Bernd Höppe, Harpreet Sidhu, Bodo B. Beck et al.|Kidney International|2006Cited by 214
Nephrocalcinosis and urolithiasis in childrenSandra Habbig, Bernd Höppe, Bodo B. Beck|Kidney International|2011Cited by 171